A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)

Clinical trial NCT02872714 · COMPLETED

Trial details

NCT number: NCT02872714
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

UC (Urothelial Cancer)

Start date: 2017-01-12
Primary completion: 2022-02-01
Enrollment: 263

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.